Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Trimeprazine 5 mg/Prednisolone 2 mg Slow Release Capsules (Vet) are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used to treat conditions such as atopy, allergic dermatitis, otitis externa, eosinophilic granuloma complex, and anal sacculitis in animals.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present the compounded formulation of Trimeprazine 5 mg/Prednisolone 2 mg Slow Release Capsules (Vet) for veterinary use. This unique formulation is designed to treat a range of conditions including allergies, skin conditions, and inflammatory diseases in animals. Trimeprazine, an antihistamine, works to alleviate itching and inflammation, while Prednisolone, a corticosteroid, aids in reducing inflammation and suppressing the immune system.
What sets this formulation apart is the use of Methocel E4M, a controlled-release polymer. This innovative ingredient ensures the gradual release of the encapsulated medication over an extended period, providing a sustained therapeutic effect. This slow-release mechanism not only offers longer-lasting relief but also reduces the frequency of dosing, thereby improving patient compliance for medications requiring a controlled and prolonged release profile.
It is crucial to understand that this formulation is intended solely for animal use and is not suitable for human consumption. It is also imperative to adhere strictly to the veterinarian's instructions when administering this medication to ensure its effectiveness and the safety of the animal.
If you have any queries regarding this formulation or its application in treating various conditions, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is always ready to assist and provide the necessary information and guidance.
This formulation of Trimeprazine 5 mg/Prednisolone 2 mg Slow Release Capsules (Vet) is specifically designed for veterinary use, offering a targeted treatment for a range of conditions including allergies, skin conditions, and inflammatory diseases. The formulation is not suitable for human use.
The combination of Trimeprazine and Prednisolone in this formulation offers a dual-action approach to treatment. Trimeprazine, an antihistamine, works to mitigate the body's response to allergens, while Prednisolone, a corticosteroid, actively reduces inflammation. This combination provides comprehensive relief from the symptoms associated with the aforementioned disease states.
These capsules are formulated with Methocel E4M, a controlled-release polymer. This ensures the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism also reduces the frequency of dosing, which can improve patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
When administering this formulation, it is crucial to monitor the patient for potential adverse reactions. These may include vomiting, diarrhea, or behavioral changes. Additionally, this formulation may cause an increase in blood pressure, so regular monitoring of the patient's blood pressure is advised.
This formulation is contraindicated in patients with a known hypersensitivity to either Trimeprazine or Prednisolone. It should also be avoided in patients with a history of glaucoma, diabetes, or any other serious medical condition. Always consult with a veterinary professional before starting any new medication regimen.
If you have any questions about this formulation or its interaction with other medications, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your veterinary pharmaceutical needs.
Trimeprazine 5 mg/Prednisolone 2 mg Slow Release Capsules (Vet) is a compounded formulation that combines two potent medications, Trimeprazine and Prednisolone, to treat a variety of conditions in animals. Trimeprazine, an antihistamine, works to alleviate inflammation and itching, while Prednisolone, a corticosteroid, aids in reducing inflammation and suppressing the immune system.
The slow release capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design ensures a gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow release mechanism reduces the frequency of dosing and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
Administration of these capsules should be done orally, preferably with food, and as directed by your veterinarian. Adherence to your veterinarian’s instructions for dosing and administration is crucial to ensure the effectiveness of the medication and the health of your pet.
Common side effects of Trimeprazine/Prednisolone include vomiting, diarrhea, and increased thirst. If your pet experiences any of these side effects, it is imperative to contact your veterinarian immediately. Other side effects may occur, so it is important to maintain open communication with your veterinarian and discuss any concerns that may arise.
If you have any questions or need further information about Trimeprazine 5 mg/Prednisolone 2 mg Slow Release Capsules (Vet), please do not hesitate to reach out. We are committed to providing the best possible care for you and your pet.
This compounded formulation of Trimeprazine 5 mg/Prednisolone 2 mg Slow Release Capsules (Vet) is designed with Methocel E4M, a controlled-release polymer. This unique formulation allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This is particularly beneficial for medications requiring a controlled and prolonged release profile.
These capsules are used to treat a wide range of conditions in veterinary medicine. These include, but are not limited to, Immune-mediated Hemolytic Anemia, Immune-mediated Thrombocytopenia, Immune-mediated Polyarthritis, Immune-mediated Glomerulonephritis, and Immune-mediated Skin Diseases. It is also used for managing Acute and Chronic Allergic Reactions, Asthma, and Bronchitis. Furthermore, it can be used to treat Acute and Chronic Skin Diseases, Dermatitis, and Pyoderma. Other conditions that can be managed with this formulation include Anal Sacculitis, Otitis Externa, and Eosinophilic Granuloma Complex.
It is crucial to understand that this formulation should only be administered under the supervision of a veterinarian. The dosage and duration of treatment should be determined by the veterinarian based on the patient’s condition and response to treatment. If you have any questions about the use of this formulation, please consult with your veterinarian.
This is a compounded veterinary medication that contains two active ingredients, Trimeprazine and Prednisolone. It is formulated with Methocel E4M, a controlled-release polymer, to gradually release the medication over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Slow-release formulations offer several benefits. They provide sustained therapeutic effects, reduce the frequency of dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
Trimeprazine is one of the active ingredients in this formulation. It is a type of antihistamine that is often used in veterinary medicine to treat allergies and itching in pets.
Prednisolone is the other active ingredient in this formulation. It is a type of corticosteroid that is often used in veterinary medicine to treat inflammation and immune system disorders in pets.
Due to the slow-release nature of this formulation, the frequency of dosing is typically reduced. However, the exact dosing schedule should be determined by a veterinarian based on the specific needs of the pet.
As with any medication, there can be potential side effects. These can vary depending on the individual pet and the dosage used. It is important to monitor your pet closely and consult with a veterinarian if any adverse reactions are observed.
This medication is typically used for dogs and cats, but it may not be suitable for all types of pets. It is important to consult with a veterinarian to determine if this medication is appropriate for your pet.
If a dose is missed, it should be given as soon as possible. However, if it is close to the time for the next dose, the missed dose should be skipped and the regular dosing schedule should be resumed. Double doses should be avoided.
This medication should be stored in a cool, dry place, away from light and out of reach of children and pets. It should not be stored in the bathroom or near a sink due to the potential for moisture damage.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
